Command Injection Risk in VMware Aria Operations

Historical catalog analysis: CISA added this entry on March 03, 2026. The entry reflects catalog information retrieved on August 31, 2026, not a snapshot archived on the inclusion date. Check current vendor guidance before acting.

What the vulnerability is

CVE-2026-22719 is a command injection vulnerability (CWE-77) affecting Broadcom VMware Aria Operations, previously known as vRealize Operations (vROps). This flaw allows an unauthenticated attacker to execute arbitrary commands on the system. If successfully exploited, this could lead to remote code execution (RCE), granting unauthorized access to the management layer of the virtualization environment.

Exposure and applicability

This vulnerability is specifically applicable during support-assisted product migrations. For healthcare organizations, Aria Operations often serves as a critical monitoring and management tool for the virtualized infrastructure that hosts electronic Protected Health Information (ePHI) and essential clinical applications. Because this tool operates at a high privilege level across the virtual environment, an unauthenticated RCE vulnerability represents a significant risk to both data confidentiality and the operational resilience of patient care systems.

Remediation priorities

Based on our analysis, healthcare IT and security leaders should prioritize the following actions to reduce exposure:

1. Vendor Mitigation Application: The primary priority is to apply mitigations as specified in Broadcom’s vendor instructions. This is the most direct method to address the underlying command injection flaw.
2. Migration Process Review: Organizations currently undergoing or planning support-assisted migrations should verify if their specific environment and version are susceptible before proceeding with migration activities.
3. Product Lifecycle Evaluation: In scenarios where mitigations cannot be applied or are unavailable, organizations should evaluate whether to discontinue use of the product to eliminate the attack vector entirely.

How to validate remediation

To confirm that exposure has been reduced, security and IT operations teams should employ the following validation methods:

• Version and Patch Verification: Confirm that the installed version of VMware Aria Operations matches the patched or mitigated versions identified in the vendor’s official security advisory.
• Configuration Audit: Review migration logs and support session records to ensure that any support-assisted migrations were conducted using the updated, mitigated processes.

Note: A version check alone does not guarantee total security, as it only confirms the presence of a specific patch and not the overall security posture of the environment.

Limits and open questions

It remains unknown whether this vulnerability has been leveraged by ransomware campaigns. Additionally, while CISA has established a remediation deadline of March 24, 2026, for federal agencies, this date is a regulatory requirement for those specific entities and not a legal mandate for private healthcare providers. The effectiveness of the mitigation depends on strict adherence to vendor-provided instructions; residual risk may remain if other configuration weaknesses exist within the virtualization management layer.

Source and editorial note

CVE-2026-22719: Broadcom VMware Aria Operations Command Injection Vulnerability · Source date: March 03, 2026 · Retrieved August 31, 2026.

Material facts are tied to the cited primary source. Recommendations are independent defensive analysis unless attributed to the source. Confirm consequential decisions against current authoritative guidance.

Archive date: March 06, 2026. The displayed post date is assigned three days after the source date to organize this retrospective archive; it does not mean this site published the analysis then. First published by this site: September 17, 2026 at 01:02 UTC.

Request a healthcare security assessment